Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized placebo-controlled trial

被引:83
作者
Buyse, Gunnar M. [1 ]
Goemans, Nathalie [1 ]
van den Hauwe, Marleen [1 ]
Thijs, Daisy [1 ]
de Groot, Imelda J. M. [2 ]
Schara, Ulrike [3 ]
Ceulemans, Berten [4 ]
Meier, Thomas [5 ]
Mertens, Luc [1 ]
机构
[1] Univ Hosp Leuven, B-3000 Louvain, Belgium
[2] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands
[3] Univ Essen Gesamthsch, Essen, Germany
[4] Univ Hosp Antwerp, Antwerp, Belgium
[5] Santhera Pharmaceut, Liestal, Switzerland
关键词
Duchenne; Muscular dystrophy; Treatment; Idebenone; Cardiac; Cardiomyopathy; Respiratory function; MYOCARDIAL DYSFUNCTION; STRAIN-RATE; MUSCLE WEAKNESS; CARDIOMYOPATHY; CHILDREN; PHARMACOKINETICS; FLOW;
D O I
10.1016/j.nmd.2011.02.016
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Early mortality in Duchenne muscular dystrophy (DMD) is related to cardiac and respiratory complications. A phase ha double-blind randomized placebo-controlled clinical trial was conducted to investigate the tolerability and efficacy of idebenone therapy in children with DMD. Twenty-one DMD patients (aged 8-16 years) were randomly assigned to daily treatment with 450 mg idebenone (Catena (R)) (n = 13) or placebo (n = 8) for 12 months. All subjects completed the study and idebenone was safe and well tolerated. Idebenone treatment resulted in a trend (p = 0.067) to increase peak systolic radial strain in the left ventricular inferolateral wall, the region of the heart that is earliest and most severely affected in DMD. A significant respiratory treatment effect on peak expiratory flow was observed (p = 0.039 for PEF and p = 0.042 for PEF percent predicted). Limitations of this study were the small sample size, and a skewed age distribution between treatment groups. Data from this study provided the basis for the planning of a confirmatory study. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:396 / 405
页数:10
相关论文
共 40 条
[1]   Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging [J].
Ashford, MW ;
Liu, W ;
Lin, SJ ;
Abraszewski, P ;
Caruthers, SD ;
Connolly, AM ;
Yu, X ;
Wickline, SA .
CIRCULATION, 2005, 112 (16) :2462-2467
[2]   Pharmacokinetics and metabolism of idebenone in healthy male subjects [J].
Bodmer, Michael ;
Vankan, Pierre ;
Dreier, Manfred ;
Kutz, Klaus W. ;
Drewe, Juergen .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (05) :493-501
[3]   Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management [J].
Bushby, Katharine ;
Finkel, Richard ;
Birnkrant, David J. ;
Case, Laura E. ;
Clemens, Paula R. ;
Cripe, Linda ;
Kaul, Ajay ;
Kinnett, Kathi ;
McDonald, Craig ;
Pandya, Shree ;
Poysky, James ;
Shapiro, Frederic ;
Tomezsko, Jean ;
Constantin, Carolyn .
LANCET NEUROLOGY, 2010, 9 (01) :77-93
[4]   Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance [J].
Buyse, Gunnar M. ;
Van der Mieren, Gerry ;
Erb, Michael ;
D'hooge, Jan ;
Herijgers, Paul ;
Verbeken, Erik ;
Jara, Alejandro ;
Van Den Bergh, An ;
Mertens, Luc ;
Courdier-Fruh, Isabelle ;
Barzaghi, Patrizia ;
Meier, Thomas .
EUROPEAN HEART JOURNAL, 2009, 30 (01) :116-124
[5]   Tissue Doppler imaging detects early asymptomatic myocardial abnormalities in a dog model of Duchenne's cardiomyopathy [J].
Chetboul, V ;
Escriou, C ;
Tessier, D ;
Richard, V ;
Pouchelon, JL ;
Thibault, H ;
Lallemand, F ;
Thuillez, C ;
Blot, S ;
Derumeaux, GE .
EUROPEAN HEART JOURNAL, 2004, 25 (21) :1934-1939
[6]   Maximal static respiratory pressures in children and adolescents [J].
Domènech-Clar, R ;
López-Andreu, JA ;
Compte-Torrero, L ;
De Diego-Damiá, A ;
Macián-Gisbert, V ;
Perpiñá-Tordera, M ;
Roqués-Serradilla, JM .
PEDIATRIC PULMONOLOGY, 2003, 35 (02) :126-132
[7]  
Emery AEH, 2003, DUCHENNE MUSCULAR DY, P6
[8]   Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children [J].
Escolar, DM ;
Henricson, EK ;
Mayhew, J ;
Florence, J ;
Leshner, R ;
Patel, KM ;
Clemens, PR .
MUSCLE & NERVE, 2001, 24 (06) :787-793
[9]   Respiratory care of the patient with duchenne muscular dystrophy - ATS Consensus Statement [J].
Finder, JD ;
Birnkrant, D ;
Carl, J ;
Farber, HJ ;
Gozal, D ;
Iannaccone, ST ;
Kovesi, T ;
Kravitz, RM ;
Panitch, H ;
Schramm, C ;
Schroth, M ;
Sharma, G ;
Sievers, L ;
Silvestri, JM ;
Sterni, L .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (04) :456-465
[10]   The heart in human dystrophinopathies [J].
Finsterer, J ;
Stöllberger, C .
CARDIOLOGY, 2003, 99 (01) :1-19